Adv. Yuval Horn participated in the 3rd Silicon Beach Conference All Along the Spectrum – From Start-Up to IPO/Exit and Beyond
February 1, 2017
Yuval Horn was noted as one of leading practitioners in Israel in the field of Information Technology by the 2017 edition of Who’s Who Legal: Telecommunications Media & Technology
January 11, 2017
Adv. Paz Abercohen joined the firm as a partner
January 10, 2017
Yuval Horn and Ohad Mamann of Horn & Co. represented the investors in ArtsAvit’s financing round, led by Pontifax, Arkin Holdings and Merck Ventures
January 5, 2017
Vascular Biogenics Ltd. (NASDAQ:VBLT) Announces $24 Million Registered Direct Offering
December 18, 2016
Yuval Horn and Paz Abercohen of Horn & Co. acted as Israeli counsel to Protalix BioTherapeutics, Inc. (NYSE: PLX) in a $54.1 Million private notes exchange agreement, and a $22.5 Million private placement of the company’s Secured Convertible Notes
December 8, 2016
IBA 2nd M&A conference in the technology sector crowned with success
October 30, 2016
Yuval Horn, Keren Kanir and Uri Dotan of Horn & Co. represented Vascular Biogenics Ltd. in its $24 Million follow-on offering on NASDAQ
June 20, 2016
Yuval Horn participates in the WHO’S WHO LEGAL’S ROUNDTABLE: LIFE SCIENCES 2016
June 20, 2016
Horn & Co. listed by iam Magazine as one of top 3 “highly recommended” Israeli firms in the field of intellectual property transactions
May 31, 2016
